Position in AXSM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,401,225
+$1,911,040 QoQ
Shares Held
26,152
-1.6% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#151
of 503 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Informed Momentum Co LLC holds $117,620,448 across 34 Biotechnology names. AXSM ranks #3 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
49,357 | $9,243,578 | |
| 2 | TVTX |
Travere Therapeutics, Inc.
|
117,987 | $6,702,841 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
This page
|
26,152 | $6,401,225 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
19,498 | $6,163,122 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
16,227 | $6,031,089 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
24,544 | $5,914,367 | |
| 7 | CYTK |
Cytokinetics Inc
|
68,185 | $5,808,680 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
120,928 | $5,688,453 |
All Filings in AXSM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,401,225 | 26,152 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,490,185 | 26,566 | Shares | Sole | 2026-05-13 | |
| 2025-03-31 | $4,924,351 | 42,222 | Shares | Sole | 2025-05-13 | |
| 2023-06-30 | $1,300,809 | 18,102 | Shares | Sole | 2023-08-11 | |
| 2022-12-31 | $1,115,145 | 14,458 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,324,345 | 52,092 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,959,428 | 51,160 | Shares | Sole | 2022-08-12 | |
| 2020-06-30 | $2,410,228 | 29,293 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,426,075 | 75,235 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||